Astrocytic EAAT-2 Upregulation Supports Neuro-Axonal Homeostasis in Chronic Inflammatory CNS Lesions.
5 affiliations
- 1Experimental and Clinical Research Center (ECRC), Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- 2Advanced Light Microscopy, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- 3Klinik für Neurologie und Experimentelle Neurologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 4Institute of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- 5Photonics Group, Physics Department, Imperial College London, London, UK.
Abstract
Neuronal loss in multiple sclerosis (MS) is a key factor in the progression of disability. Axonal degeneration within MS lesions is central to progressive MS pathology, yet its mechanisms are not fully understood. Excess extracellular l-glutamate (GLUT) is neurotoxic due to overstimulation of GLUT receptors. Excitotoxicity, driven by GLUT, is a suspected contributor to several central nervous system (CNS) diseases. Astrocytic glutamate transporters EAAT-1 and EAAT-2 play crucial roles in managing extracellular GLUT, yet their role in chronic MS remains underexplored. Using the animal model experimental autoimmune encephalomyelitis (EAE) and advanced microscopy in live anesthetized mice, we examined GLUT-mediated neurotoxicity and protective mechanisms in chronic CNS lesions. By employing genetically encoded fluorescent biosensors, we visualized extracellular GLUT levels and axonal Ca²⁺ dynamics within the live mouse brain during EAE. In acute EAE, extracellular GLUT levels were high, while in chronic lesions, normalized GLUT levels together with sustained EAAT-2 upregulation were consistent with a protective astrocytic response. EAAT-2 inhibition in chronic lesions led to higher intra-axonal Ca²⁺ levels and morphological changes consistent with neuroaxonal injury, indicating that EAAT-2 upregulation may counter excitotoxicity and support neuroprotection. Post-mortem MS brain tissue analysis provided complementary evidence, showing elevated EAAT-1 and EAAT-2 expression in chronic MS lesions with expression patterns varying according to lesion type and cellularity. This study highlights astrocytic mechanisms that may contribute to neuroaxonal protection in MS tissue and suggests targeting GLUT transporters as a promising strategy to limit neurodegeneration in progressive MS.
Related
- Intranasal L-MYC Neural Stem Cells Restore Neurovascular and Neuroimmune Homeostasis After TBI via CX3CL1 Upregulation and ICAM-1 Downregulation
- Cross-Tissue Inflammatory Convergence Supports a Putative Muscle-Brain Axis in Alzheimer's Disease
- A dual role of AcSDKP in chronic kidney disease: Targeting pericyte-driven fibrosis and vascular repair via VEGF/FGFR1 while eliciting a compensatory FGFR1 upregulation in apoptotic tubular cells
- Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis.
- Arginine Kinase 1 supports energy homeostasis in Drosophila flight muscle development
BibTeX
@article{reukauf2026astrocytic,
title = {{Astrocytic EAAT-2 Upregulation Supports Neuro-Axonal Homeostasis in Chronic Inflammatory CNS Lesions.}},
author = {Luise Reukauf and Anca Margineanu and Bakhrom Muinjonov and Jessy Chen and Yiqin Cui and Kamil Rosiewicz and Helena Radbruch and Ian Munro and Marlen Alisch and Volker Siffrin},
journal = {Glia},
year = {2026},
month = oct,
doi = {10.1002/glia.70243},
url = {https://europepmc.org/article/MED/42925125},
note = {CC BY},
}
RIS
TY - JOUR
TI - Astrocytic EAAT-2 Upregulation Supports Neuro-Axonal Homeostasis in Chronic Inflammatory CNS Lesions.
AU - Luise Reukauf
AU - Anca Margineanu
AU - Bakhrom Muinjonov
AU - Jessy Chen
AU - Yiqin Cui
AU - Kamil Rosiewicz
AU - Helena Radbruch
AU - Ian Munro
AU - Marlen Alisch
AU - Volker Siffrin
PY - 2026
DA - 2026/10/30
JO - Glia
DO - 10.1002/glia.70243
UR - https://europepmc.org/article/MED/42925125
AB - Neuronal loss in multiple sclerosis (MS) is a key factor in the progression of disability. Axonal degeneration within MS lesions is central to progressive MS pathology, yet its mechanisms are not fully understood. Excess extracellular l-glutamate (GLUT) is neurotoxic due to overstimulation of GLUT receptors. Excitotoxicity, driven by GLUT, is a suspected contributor to several central nervous system (CNS) diseases. Astrocytic glutamate transporters EAAT-1 and EAAT-2 play crucial roles in managing extracellular GLUT, yet their role in chronic MS remains underexplored. Using the animal model experimental autoimmune encephalomyelitis (EAE) and advanced microscopy in live anesthetized mice, we examined GLUT-mediated neurotoxicity and protective mechanisms in chronic CNS lesions. By employing genetically encoded fluorescent biosensors, we visualized extracellular GLUT levels and axonal Ca²⁺ dynamics within the live mouse brain during EAE. In acute EAE, extracellular GLUT levels were high, while in chronic lesions, normalized GLUT levels together with sustained EAAT-2 upregulation were consistent with a protective astrocytic response. EAAT-2 inhibition in chronic lesions led to higher intra-axonal Ca²⁺ levels and morphological changes consistent with neuroaxonal injury, indicating that EAAT-2 upregulation may counter excitotoxicity and support neuroprotection. Post-mortem MS brain tissue analysis provided complementary evidence, showing elevated EAAT-1 and EAAT-2 expression in chronic MS lesions with expression patterns varying according to lesion type and cellularity. This study highlights astrocytic mechanisms that may contribute to neuroaxonal protection in MS tissue and suggests targeting GLUT transporters as a promising strategy to limit neurodegeneration in progressive MS.
SN - 0894-1491
SN - 1098-1136
ER -